This inventor holds 3 USPTO granted patents. Top assignee: Korea Research Institute of Chemical Technology. Active years: 1993-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993-1996
Title: Kyu S Jung: Innovator in Benzopyran Derivatives
Introduction
Kyu S Jung is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of chemical technology, particularly in the development of novel benzopyran derivatives. His work focuses on creating effective treatments for asthma and hypertension.
Latest Patents
Kyu S Jung holds 3 patents that showcase his innovative approach to medicinal chemistry. His latest patents include certain pyridyl-benzopyran derivatives, which are designed to provide excellent effectiveness in treating asthma and hypertension. The compounds are characterized by specific chemical structures that enhance their therapeutic potential. Another notable patent involves spiro-benzopyran derivatives, which also target asthma and hypertension, demonstrating his commitment to addressing critical health issues through innovative solutions.
Career Highlights
Kyu S Jung is affiliated with the Korea Research Institute of Chemical Technology, where he conducts research and development in chemical technology. His work has been instrumental in advancing the understanding and application of benzopyran derivatives in medicine. His contributions have been recognized within the scientific community, further establishing his reputation as a leading inventor in his field.
Collaborations
Kyu S Jung has collaborated with notable colleagues, including Seon-Ju Kim and Byung Ho Lee. These partnerships have fostered a collaborative environment that enhances the research and development of innovative chemical solutions.
Conclusion
Kyu S Jung's work in developing benzopyran derivatives represents a significant advancement in the treatment of asthma and hypertension. His innovative approach and dedication to research continue to impact the field of chemical technology positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
